New research aims to get closer whether GLP-1s are worth the cost

A fierce debate is underway over who needs treatment with GLP-1s and who should pay for that treatment. New research aims to get closer to the answer.

Michele Tedder remembers what it felt like to live with obesity from childhood into adulthood, dealing with regular health problems and stigma around her weight.

Subscribe to read this story ad-free

Get unlimited access to ad-free articles and exclusive content.

Just a moment.

We are getting your experience ready.